Cargando…

Impact of Age and Comorbidity on Choice and Outcome of Two Different Treatment Options for Patients with Potentially Curable Esophageal Cancer

PURPOSE: This study was designed to assess the impact of age and comorbidity on choice and outcome of definitive chemoradiotherapy (dCRT) or neoadjuvant chemoradiotherapy plus surgery. METHODS: In this population-based study, all patients with potentially curable EC (cT1N+/cT2-3, TX, any cN, cM0) di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Faiz, Z., van Putten, M., Verhoeven, R. H. A., van Sandick, J. W., Nieuwenhuijzen, G. A. P., van der Sangen, M. J. C., Lemmens, V. E. P. P., Wijnhoven, B. P. L., Plukker, J. T. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Thoracic Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399439/ https://www.ncbi.nlm.nih.gov/pubmed/30719634 http://dx.doi.org/10.1245/s10434-019-07181-6

Ejemplares similares

Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy
por: Hulshoff, J. B., et al.
Publicado: (2015)

Value of EUS in Determining Curative Resectability in Reference to CT and FDG-PET: The Optimal Sequence in Preoperative Staging of Esophageal Cancer?
por: Schreurs, L. M. A., et al.
Publicado: (2011)

The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma
por: van Hootegem, Sander J. M., et al.
Publicado: (2019)

Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer
por: Talsma, Koen, et al.
Publicado: (2012)

Quality of Life During and After Completion of Neoadjuvant Chemoradiotherapy for Esophageal and Junctional Cancer
por: Noordman, B. J., et al.
Publicado: (2019)

Impact of Endoscopic Ultrasonography on (18)F-FDG-PET/CT Upfront Towards Patient Specific Esophageal Cancer Treatment
por: Hulshoff, J. B., et al.
Publicado: (2017)

Characteristics Predicting Short-Term and Long-Term Health-Related Quality of Life in Patients with Esophageal Cancer After Neoadjuvant Chemoradiotherapy and Esophagectomy
por: van der Wilk, Berend J., et al.
Publicado: (2023)

A Propensity Score-Matched Cohort Study to Evaluate the Association of Lymph Node Retrieval with Long-Term Overall Survival in Patients with Esophageal Cancer
por: van der Werf, Leonie R., et al.
Publicado: (2020)

Effect of Extending the Original CROSS Criteria on Tumor Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients: A National Multicenter Cohort Analysis
por: Wang, Helena Hong, et al.
Publicado: (2020)

A Population-based Study on Lymph Node Retrieval in Patients with Esophageal Cancer: Results from the Dutch Upper Gastrointestinal Cancer Audit
por: van der Werf, L. R., et al.
Publicado: (2018)

Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer
por: Visser, E., et al.
Publicado: (2016)

Oncologic Long-Term Results of Robot-Assisted Minimally Invasive Thoraco-Laparoscopic Esophagectomy with Two-Field Lymphadenectomy for Esophageal Cancer
por: van der Sluis, P. C., et al.
Publicado: (2015)

Prognosis and Treatment After Diagnosis of Recurrent Esophageal Carcinoma Following Esophagectomy with Curative Intent
por: Parry, K., et al.
Publicado: (2015)

Risk of Thromboembolic Events after Perioperative Chemotherapy Versus Surgery Alone for Esophageal Adenocarcinoma
por: Verhage, Roy J. J., et al.
Publicado: (2011)

Postoperative Complications and Long-Term Quality of Life After Multimodality Treatment for Esophageal Cancer: An Analysis of the Prospective Observational Cohort Study of Esophageal-Gastric Cancer Patients (POCOP)
por: Jezerskyte, E., et al.
Publicado: (2021)

The Value of Paratracheal Lymphadenectomy in Esophagectomy for Adenocarcinoma of the Esophagus or Gastroesophageal Junction: A Systematic Review of the Literature
por: Gantxegi, Amaia, et al.
Publicado: (2021)

Salvage Robot-Assisted Minimally Invasive Esophagectomy (RAMIE) for T4b Esophageal Cancer After Definitive Chemoradiotherapy
por: Defize, I. L., et al.
Publicado: (2020)

Cardiorespiratory Comorbidity and Postoperative Complications following Esophagectomy: a European Multicenter Cohort Study
por: Klevebro, F., et al.
Publicado: (2019)

Major Intraoperative Complications During Minimally Invasive Esophagectomy
por: Söderström, H., et al.
Publicado: (2023)

Feasibility and Safety of Tailored Lymphadenectomy Using Sentinel Node-Navigated Surgery in Patients with High-Risk T1 Esophageal Adenocarcinoma
por: Frederiks, Charlotte N., et al.
Publicado: (2023)

Transthoracic Versus Transhiatal Esophagectomy for Esophageal Cancer: A Nationwide Propensity Score-Matched Cohort Analysis
por: Mertens, Alexander C., et al.
Publicado: (2020)

Differences in Esophageal Cancer Surgery in Terms of Surgical Approach and Extent of Lymphadenectomy: Findings of an International Survey
por: van Rijswijk, A. S., et al.
Publicado: (2019)

A Highly Active and Tolerable Neoadjuvant Regimen Combining Paclitaxel, Carboplatin, 5-FU, and Radiation Therapy in Patients with Stage II and III Esophageal Cancer
por: van de Schoot, L., et al.
Publicado: (2007)

External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer
por: Brinkmann, Sebastian, et al.
Publicado: (2019)

Preoperative Risk Stratification in Esophageal Cancer Surgery: Comparing Risk Models with the Clinical Judgment of the Surgeon
por: Hagens, Eliza R. C., et al.
Publicado: (2023)

Tracheal cancer: a rare and deadly but potentially curable disease that also affects younger people
por: Nilssen, Yngvar, et al.
Publicado: (2023)

Optimal Perioperative Pain Management in Esophageal Surgery: An Evaluation of Paravertebral Analgesia
por: Feenstra, Minke L., et al.
Publicado: (2021)

Adequate Lymphadenectomy as a Quality Measure in Esophageal Cancer: Is there an Association with Treatment Approach?
por: Schlick, Cary Jo R., et al.
Publicado: (2020)

Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery
por: Reisinger, Kostan W., et al.
Publicado: (2015)

Treatment Patterns and Outcomes of Elderly Patients With Potentially Curable Esophageal Cancer
por: Yang, Yang, et al.
Publicado: (2022)

Extent of Lymphadenectomy in Esophageal Cancer: How Many Lymph Nodes Is Enough?
por: Herrera, Luis J.
Publicado: (2009)

Anastomotic Leak Does Not Impact on Long-Term Outcomes in Esophageal Cancer Patients
por: Kamarajah, S. K., et al.
Publicado: (2020)

Patient Age and Survival After Surgery for Esophageal Cancer
por: Lagergren, Jesper, et al.
Publicado: (2020)

Staged single-port thoracoscopic R2 sympathicotomy as a reproducible, safe and effective treatment option for debilitating severe facial blushing
por: van der Weijde, Emma, et al.
Publicado: (2022)

Prevalence and Prognostic Significance of Extramural Venous Invasion in Patients with Locally Advanced Esophageal Cancer
por: Faiz, Zohra, et al.
Publicado: (2018)

Wedge resection is an acceptable treatment option for radiologically low-grade lung cancer with solid predominance
por: Kamigaichi, Atsushi, et al.
Publicado: (2023)

Predicting the Risk of Weight Loss After Esophageal Cancer Surgery
por: Schandl, Anna, et al.
Publicado: (2019)

Life Expectancy in Survivors of Esophageal Cancer Compared with the Background Population
por: Lundberg, Ellinor, et al.
Publicado: (2022)

Non-Small-Cell Lung Cancer Patients with a High Predicted Risk of Irradical Resection: Can Chemoradiotherapy Offer Similar Survival?
por: van Joolingen, W. Hugo, et al.
Publicado: (2021)

Centralization of Esophageal Cancer Surgery: The Right Thing to Do Is Seldom Easy
por: DeMeester, Steven
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_q4kphgipr7lu7tgckncuv0kmif